Cosentyx (secukinumab) — Point32Health

Initial criteria

• Documented diagnosis of psoriatic arthritis
• Patient age ≥ 2 years
• Prescribed by or in consultation with a rheumatologist or dermatologist
• Documentation of one (1) of the following: (a) Trial and failure of at least two of the listed medications from each of the following therapeutic categories (only one medication is required if only one is available for that category): Interleukin Antagonists (Bimzelx, Skyrizi, Taltz, Tremfya, Yesintek), Janus Kinase Inhibitors (Rinvoq, Xeljanz), Phosphodiesterase 4 inhibitors (Otezla), Selective T Cell Stimulators (Orencia), Tumor Necrosis Factors (Cimzia, Enbrel, Humira, Simponi); OR (b) Contraindication to all the following medications: Bimzelx, Skyrizi, Taltz, Tremfya, Yesintek, Rinvoq, Xeljanz, Otezla, Orencia, Cimzia, Enbrel, Humira, Simponi